News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,697 Results
Type
Article (50491)
Company Profile (287)
Press Release (688919)
Multimedia
Podcasts (76)
Webinars (12)
Section
Business (212805)
Career Advice (2169)
Deals (36673)
Drug Delivery (111)
Drug Development (84011)
Employer Resources (177)
FDA (17030)
Job Trends (15790)
News (360316)
Policy (34822)
Tag
Academia (2793)
Academic (1)
Accelerated approval (5)
Adcomms (24)
Allergies (89)
Alliances (51766)
ALS (103)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (142)
Approvals (17025)
Artificial intelligence (288)
Autoimmune disease (24)
Automation (17)
Bankruptcy (375)
Best Places to Work (12111)
BIOSECURE Act (21)
Biosimilars (110)
Biotechnology (197)
Bladder cancer (81)
Brain cancer (28)
Breast cancer (303)
Cancer (2384)
Cardiovascular disease (195)
Career advice (1818)
Career pathing (32)
CAR-T (161)
Cell therapy (449)
Cervical cancer (22)
Clinical research (68238)
Collaboration (893)
Company closure (2)
Compensation (568)
Complete response letters (22)
COVID-19 (2772)
CRISPR (44)
C-suite (263)
Cystic fibrosis (104)
Data (2359)
Decentralized trials (2)
Denatured (29)
Depression (52)
Diabetes (284)
Diagnostics (6601)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (114)
Drug shortages (28)
Duchenne muscular dystrophy (99)
Earnings (89338)
Editorial (44)
Employer branding (22)
Employer resources (149)
Events (118172)
Executive appointments (760)
FDA (18457)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (795)
Gene editing (115)
Generative AI (26)
Gene therapy (328)
GLP-1 (785)
Government (4731)
Grass and pollen (4)
Guidances (158)
Healthcare (19939)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (129)
Indications (30)
Infectious disease (2924)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (100)
Interviews (344)
IPO (16945)
IRA (42)
Job creations (4096)
Job search strategy (1550)
Kidney cancer (10)
Labor market (45)
Layoffs (507)
Leadership (18)
Legal (8493)
Liver cancer (79)
Lung cancer (338)
Lymphoma (158)
Machine learning (9)
Management (58)
Manufacturing (336)
MASH (80)
Medical device (14397)
Medtech (14402)
Mergers & acquisitions (20304)
Metabolic disorders (753)
Multiple sclerosis (86)
NASH (16)
Neurodegenerative disease (109)
Neuropsychiatric disorders (33)
Neuroscience (2043)
NextGen: Class of 2025 (6942)
Non-profit (4745)
Now hiring (41)
Obesity (399)
Opinion (227)
Ovarian cancer (83)
Pain (96)
Pancreatic cancer (89)
Parkinson's disease (157)
Partnered (22)
Patents (248)
Patient recruitment (117)
Peanut (48)
People (60292)
Pharmaceutical (70)
Pharmacy benefit managers (20)
Phase I (21260)
Phase II (30023)
Phase III (22401)
Pipeline (1382)
Policy (156)
Postmarket research (2741)
Preclinical (9078)
Press Release (67)
Prostate cancer (111)
Psychedelics (35)
Radiopharmaceuticals (258)
Rare diseases (400)
Real estate (6327)
Recruiting (67)
Regulatory (23827)
Reports (49)
Research institute (2495)
Resumes & cover letters (370)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (80)
Series A (132)
Series B (91)
Service/supplier (13)
Sickle cell disease (54)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (32)
Startups (3862)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (51)
The Weekly (45)
Vaccines (760)
Venture capitalists (43)
Weight loss (270)
Women's health (39)
Worklife (17)
Date
Today (201)
Last 7 days (985)
Last 30 days (3191)
Last 365 days (33423)
2025 (12194)
2024 (36245)
2023 (41275)
2022 (52545)
2021 (57228)
2020 (56025)
2019 (48881)
2018 (37000)
2017 (33926)
2016 (33700)
2015 (39713)
2014 (33435)
2013 (28637)
2012 (30931)
2011 (31622)
2010 (29994)
Location
Africa (813)
Alabama (55)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (41357)
Australia (6831)
California (6496)
Canada (2083)
China (564)
Colorado (286)
Connecticut (297)
Delaware (163)
Europe (89642)
Florida (965)
Georgia (224)
Idaho (61)
Illinois (588)
India (26)
Indiana (329)
Iowa (11)
Japan (175)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (964)
Massachusetts (4887)
Michigan (233)
Minnesota (420)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (70)
New Hampshire (68)
New Jersey (1827)
New Mexico (29)
New York (1832)
North Carolina (1064)
North Dakota (8)
Northern California (2853)
Ohio (212)
Oklahoma (14)
Oregon (35)
Pennsylvania (1449)
Puerto Rico (13)
Rhode Island (35)
South America (1204)
South Carolina (26)
South Dakota (1)
Southern California (2441)
Tennessee (107)
Texas (965)
United States (24612)
Utah (192)
Virginia (156)
Washington D.C. (68)
Washington State (588)
West Virginia (3)
Wisconsin (58)
739,697 Results for "bio2 medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
March 18, 2025
·
5 min read
Press Releases
Incyclix Bio Announces Publication in Nature Communications Highlighting Biomarkers of Response to CDK2 Inhibition
February 14, 2025
·
2 min read
Press Releases
2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
May 8, 2025
·
19 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
May 7, 2025
·
8 min read
Press Releases
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
March 11, 2025
·
19 min read
Press Releases
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
February 25, 2025
·
1 min read
Press Releases
GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
May 8, 2025
·
8 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
1 of 73,970
Next
